Open AccessSiglec-6 is a target for chimeric antigen receptor T-cell treatment of chronic lymphocytic leukemia
Author(s) -
Damián Kovalovsky,
Jeong Heon Yoon,
Matthew G. Cyr,
Samantha Simon,
Elisaveta Voynova,
Christoph Rader,
Adrian Wiestner,
Julie Alejo,
Stefania Pittaluga,
Ronald E. Gress
Publication year - 2021
Publication title -
leukemia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.539
H-Index - 192
eISSN - 1476-5551
pISSN - 0887-6924
DOI - 10.1038/s41375-021-01188-3
Subject(s) - chimeric antigen receptor , siglec , chronic lymphocytic leukemia , cd19 , antigen , cancer research , stem cell , immunology , haematopoiesis , leukemia , biology , immunotherapy , immune system , microbiology and biotechnology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom